Study: Survival Not Affected by Discordant Pathology in High-Grade UTUC
Among patients with high-grade UTUC, overall survival did not differ significantly between patients with discordant vs concordant pathologies.
Among patients with high-grade UTUC, overall survival did not differ significantly between patients with discordant vs concordant pathologies.
Following radical prostatectomy, prostate cancer-specific survival at 10 years was 91% for patients with detectable PSA and 99% for those with undetectable PSA, a study found.
Patients who received intravesical docetaxel, gemcitabine, and cisplatin for BCG-refractory nonmuscle-invasive bladder cancer had initial downgrading, downstaging, or both.
Patients receiving modern immunotherapy for metastatic renal cell carcinoma have a decreased risk of death if they also undergo cytoreductive nephrectomy, a study found.
Higher body mass index, a history of chronic obstructive pulmonary diseases, and black race are associated with an increased risk of reoperation within 30 days of racial cystectomy, a study found.
A study found better cancer-specific survival among men with metastatic castration-resistant prostate cancer who received chemo before antiandrogens.
The Society of Urologic Oncology (SUO) convenes its 20th Annual Scientific Meeting in Washington, DC, from December 4 to 6 at the Renaissance Washington DC Downtown Hotel.